Skip to main content
Log in

Adverse Drug Reaction Monitoring

The Practicalities

  • Leading Article
  • Published:
Medical Toxicology and Adverse Drug Experience Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • CoulterDM, et al. In Inman WHW (Ed.) Monitoring for drug safety, 2nd ed, pp. 119–133, MTP Press, 1986

  • Davies DM, et al. In Davies DM (Ed.) Textbook of adverse drug reactions, 3rd ed, pp. 12–38, Oxford University Press, Oxford, 1985

  • Edwards IR. Agranulocytosis and mianserin. New Zealand Medical Journal 98: 772, 1985

    Google Scholar 

  • Inman WHW. In Inman WHW (Ed.) Monitoring for drug safety, 2nd ed, pp. 5–11, MTP Press, 1986

  • McEwen J, Strickland WJ. Mebhydrolin napadisylate: a possible cause of reversible agranulocytosis and neutropenia. Medical Journal of Australia 2: 523, 1983

    Google Scholar 

  • Rawlins MD, Thompson JW. Pathogenesis of adverse reactions. In Davies (Ed.) Textbook of adverse drug reactions, Oxford University Press, Oxford, 1977

    Google Scholar 

  • Stephens MDB. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug Reaction and Acute Poisoning Reviews 6: 1, 1987

    CAS  Google Scholar 

  • Yenning GR. Rare and serious adverse reactions. Medical Toxicology 2: 235–241, 1987

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, I.R. Adverse Drug Reaction Monitoring. Med Toxicol Adverse Drug Exp 2, 405–410 (1987). https://doi.org/10.1007/BF03259875

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259875

Keywords

Navigation